covid
Document de presse
2021.07.01
On April 7, 2021, the European Medical Agency (EMA) concluded that thrombosis in combination with thrombocytopenia has been identified as a likely adverse...
Document de presse
2021.05.27
A study conducted by the University Hospital of Strasbourg (HUS) in collaboration with the Institut Pasteur, published as a preprint on medRxiv, has led to a...
Document de presse
2021.05.28
The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world. It is now dominant in many countries and...
News
2021.05.03
Free et Self-paced
Emerging and re-emerging viruses are key players among the different pathogens that have caused recent epidemics, as attested by several...
News
2021.03.30
Since the beginning of the COVID-19 pandemic, and increasingly rapidly thereafter, the Institut Pasteur International Network has drawn heavily on all its...
Document de presse
2021.03.23
SARS-CoV-2, the virus responsible for COVID-19, is capable of infecting some species, while others are naturally resistant to it. This determines the "host...
Document de presse
2021.03.26
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries....
News
2021.03.24
ERA4TB (the European Regimen Accelerator for Tuberculosis) is a 6-year public-private partnership with a total budget of over €200M that began in 2020 with the...
News
2021.03.03
After more than three years of activities in the underprivileged regions of the Centre and South of Tunisia, the second phase of the ATun-DIP's project (...
Report
2021.02.22
The Institut Pasteur is one of the world's leading centers for research on infectious diseases. This area is therefore one of the priority research areas of...